Healthcare provider profile · identity verified

Brian Chase, AGACNP-BC

Nurse Practitioner · ROCKY HILL, CT · NPI 1568025146

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	287	32
Pantoprazole Sodium	Pantoprazole Sodium	247	30
Amlodipine Besylate	Amlodipine Besylate	207	23
Gabapentin	Gabapentin	195	24
Rosuvastatin Calcium	Rosuvastatin Calcium	189	19
Metoprolol Succinate	Metoprolol Succinate	180	20
Furosemide	Furosemide	176	22
Levothyroxine Sodium	Levothyroxine Sodium	164	14
Lisinopril	Lisinopril	155	15
Hydrochlorothiazide	Hydrochlorothiazide	143	16
Eliquis	Apixaban	135	19
Duloxetine Hcl	Duloxetine Hcl	122	13
Tamsulosin Hcl	Tamsulosin Hcl	116	14
Trulicity	Dulaglutide	113	18
Omeprazole	Omeprazole	111	12
Potassium Chloride	Potassium Chloride	111	14
Sertraline Hcl	Sertraline Hcl	108	11
Trazodone Hcl	Trazodone Hcl	91	13
Losartan Potassium	Losartan Potassium	86	14
Simvastatin	Simvastatin	85	12
Dapagliflozin	Dapagliflozin Propanediol	83	suppressed
Torsemide	Torsemide	81	suppressed
Mirtazapine	Mirtazapine	80	12
Metformin Hcl	Metformin Hcl	79	13
Entresto	Sacubitril/Valsartan	78	suppressed
Finasteride	Finasteride	78	suppressed
Allopurinol	Allopurinol	77	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	77	suppressed
Famotidine	Famotidine	75	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	74	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	72	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	70	suppressed
Lamotrigine	Lamotrigine	69	suppressed
Propranolol Hcl	Propranolol Hcl	67	suppressed
Spironolactone	Spironolactone	62	suppressed
Carvedilol	Carvedilol	59	suppressed
Hydralazine Hcl	Hydralazine Hcl	59	suppressed
Citalopram Hbr	Citalopram Hydrobromide	56	suppressed
Ozempic	Semaglutide	55	suppressed
Risperidone	Risperidone	54	suppressed
Ezetimibe	Ezetimibe	53	suppressed
Oxycodone Hcl	Oxycodone Hcl	53	15
Donepezil Hcl	Donepezil Hcl	50	suppressed
Metformin Hcl Er	Metformin Hcl	48	suppressed
Topiramate	Topiramate	47	suppressed
Lorazepam	Lorazepam	46	12
Levetiracetam	Levetiracetam	44	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	41	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	40	suppressed
Tramadol Hcl	Tramadol Hcl	40	12
Clopidogrel	Clopidogrel Bisulfate	37	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	37	suppressed
Timolol Maleate	Timolol Maleate	37	suppressed
Valsartan	Valsartan	36	suppressed
Bupropion Xl	Bupropion Hcl	34	suppressed
Jardiance	Empagliflozin	33	suppressed
Memantine Hcl	Memantine Hcl	33	suppressed
Montelukast Sodium	Montelukast Sodium	32	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	29	16
Temazepam	Temazepam	29	suppressed
Atenolol	Atenolol	28	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	28	suppressed
Olanzapine Odt	Olanzapine	28	suppressed
Prednisone	Prednisone	28	13
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	27	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	27	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	27	suppressed
Alendronate Sodium	Alendronate Sodium	26	suppressed
Carbamazepine Er	Carbamazepine	26	suppressed
Clonazepam	Clonazepam	26	suppressed
Midodrine Hcl	Midodrine Hcl	26	suppressed
Pravastatin Sodium	Pravastatin Sodium	26	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	26	22
Tizanidine Hcl	Tizanidine Hcl	26	suppressed
Gabapentin Er	Gabapentin	25	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	24	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	24	suppressed
Jantoven	Warfarin Sodium	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	16
Celecoxib	Celecoxib	23	suppressed
Methenamine Hippurate	Methenamine Hippurate	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Xarelto	Rivaroxaban	23	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	22	suppressed
Gemtesa	Vibegron	22	suppressed
Mirabegron Er	Mirabegron	22	suppressed
Benztropine Mesylate	Benztropine Mesylate	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Latanoprost	Latanoprost	21	suppressed
Aripiprazole	Aripiprazole	20	suppressed
Divalproex Sodium Er	Divalproex Sodium	20	suppressed
Fosfomycin Tromethamine	Fosfomycin Tromethamine	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	19	suppressed
Baclofen	Baclofen	18	suppressed
Divalproex Sodium	Divalproex Sodium	18	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Prazosin Hcl	Prazosin Hcl	18	suppressed
Cyclosporine	Cyclosporine	16	suppressed
Fluticasone Propionate	Fluticasone Propionate	16	suppressed
Nystatin	Nystatin	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	16	suppressed
Amiodarone Hcl	Amiodarone Hcl	15	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	15	13
Irbesartan	Irbesartan	15	suppressed
Metformin Er Osmotic	Metformin Hcl	15	suppressed
Brilinta	Ticagrelor	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Fenofibrate	Fenofibrate,micronized	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	14	suppressed
Perphenazine	Perphenazine	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Varenicline Tartrate	Varenicline Tartrate	14	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	14	suppressed
Bumetanide	Bumetanide	13	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	13	suppressed
Cefdinir	Cefdinir	13	11
Desloratadine	Desloratadine	13	suppressed
Donepezil Hcl Odt	Donepezil Hcl	13	suppressed
Felodipine Er	Felodipine	13	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Glyburide	Glyburide	13	suppressed
Glycopyrrolate	Glycopyrrolate	13	suppressed
Haloperidol	Haloperidol	13	suppressed
Insulin Aspart Flexpen	Insulin Aspart	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Oxcarbazepine	Oxcarbazepine	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Repatha Syringe	Evolocumab	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	12	suppressed
Repatha Sureclick	Evolocumab	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	11	suppressed
Estring	Estradiol	11	suppressed
Haloperidol Decanoate	Haloperidol Decanoate	11	suppressed
Tiotropium Bromide	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error